Literature DB >> 6794796

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.

M E Sprackling, J R Mitchell, A H Short, G Watt.   

Abstract

A total of 123 out of 549 elderly residents of local authority welfare homes in Nottinghamshire were found at screening to have a standing or lying diastolic blood pressure of 100 mm Hg or more. These 123 subjects were randomly allocated to simple observation or to treatment with methyldopa. The cumulative mortality was similar in the observed and treated groups and in the normotensive group from which the subjects had been separated. Thus moderate hypertension, whether treated or not, was not a major risk predictor in the elderly population studied.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794796      PMCID: PMC1507336          DOI: 10.1136/bmj.283.6300.1151

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

Review 2.  Clinical management of venous thrombo-embolism.

Authors:  G K Morris; J R Mitchell
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

Review 3.  Drug therapy: Management of hypertension in the elderly.

Authors:  J Koch-Weser; K O'Malley; E O'Brien
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

4.  Arterial hypertension in old age.

Authors:  J Koch-Weser
Journal:  Herz       Date:  1978-08       Impact factor: 1.443

5.  Hypertension in the elderly.

Authors:  W M Kirkendall; J J Hammond
Journal:  Arch Intern Med       Date:  1980-09

6.  Failure of therapy to improve prognosis in elderly males with hypertension.

Authors:  T O Morgan; W R Adams; M Hodgson; R W Gibberd
Journal:  Med J Aust       Date:  1980-07-12       Impact factor: 7.738

7.  Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly.

Authors:  A Amery; P Berthaux; C Bulpitt; M Deruyttere; A de Schaepdryver; C Dollery; R Fagard; F Forette; J Hellemans; P Lund-Johansen; A Mutsers; J Tuomilehto
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

8.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  8 in total
  18 in total

Review 1.  Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

Authors:  J M Wright; C H Lee; G K Chambers
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

Review 2.  Hypertension in the elderly.

Authors:  P Larochelle
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change.

Authors:  F Gueyffier; J Wright
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

4.  Treatment of high blood pressure: should clinical practice be based on results of clinical trials?

Authors:  R G Wilcox; J R Mitchell; J R Hampton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

Review 5.  "But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

6.  Benefits of treatment of mild to moderate hypertension.

Authors:  C H Hennekens
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

7.  Blood pressure and five year survival in the very old.

Authors:  K Mattila; M Haavisto; S Rajala; R Heikinheimo
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

Review 8.  Pharmacotherapy for hypertension in adults aged 18 to 59 years.

Authors:  Vijaya M Musini; Francois Gueyffier; Lorri Puil; Douglas M Salzwedel; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2017-08-16

Review 9.  Review of the major hypertension trials in the elderly.

Authors:  J Staessen; R Fagard; P Lijnen; R Van Hoof; A Amery
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

10.  [The status of hypertensive therapy in old age].

Authors:  J Blumenstock
Journal:  Soz Praventivmed       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.